Skip to Content
Morningstar

Nicholas Equity Income I NSEIX

Morningstar Medalist Rating
Medalist Rating as of | See Nicholas Investment Hub
  • NAV / 1-Day Return 21.73  /  +1.02 %
  • Total Assets 463.3 Mil
  • Adj. Expense Ratio
    0.700%
  • Expense Ratio 0.700%
  • Distribution Fee Level Below Average
  • Share Class Type No Load
  • Category Large Value
  • Investment Style Large Value
  • Min. Initial Investment 500
  • Status Open
  • TTM Yield 2.04%
  • Turnover 12%

USD | NAV as of Jul 26, 2024 | 1-Day Return as of Jul 26, 2024, 10:17 PM GMT+0

Morningstar’s Analysis NSEIX

Will NSEIX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

  • Process Pillar

    The Process Pillar is our assessment of how sensible, clearly defined, and repeatable NSEIX’s performance objective and investment process is for both security selection and portfolio construction.

  • People Pillar

    The People Pillar is our evaluation of the NSEIX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.

  • Parent Pillar

    The Parent Pillar is our rating of NSEIX’s parent organization’s priorities and whether they’re in line with investors’ interests.

A sound investment process and strong management team underpin Nicholas Equity Income I's Morningstar Medalist Rating of Gold.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a cost advantage over competitors, priced within the second-cheapest fee quintile among peers.

by Morningstar Manager Research
Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings NSEIX

More NSEIX Holdings
  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings —
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Microsoft Corp

3.54 16.7 Mil
Technology

JPMorgan Chase & Co

2.61 12.3 Mil
Financial Services

AstraZeneca PLC ADR

2.28 10.8 Mil
Healthcare

AbbVie Inc

2.22 10.5 Mil
Healthcare

TJX Companies Inc

2.18 10.3 Mil
Consumer Cyclical

Abbott Laboratories

2.14 10.1 Mil
Healthcare

CMS Energy Corp

2.14 10.1 Mil
Utilities

Merck & Co Inc

2.09 9.9 Mil
Healthcare

Charles Schwab Corp

2.06 9.7 Mil
Financial Services

Medtronic PLC

2.01 9.5 Mil
Healthcare